Kidswell Bio Announces January Exercise

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 2, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Kidswell Bio Announces January Exercise Status of Convertible Bonds and Warrants

Source disclosure: February 02, 2026 Kidswell Bio Corporation [4584.T] TOKYO, Feb 02 (Pulse News Wire) – Kidswell Bio Corporation (4584.T) reported the exercise status of its fourth series of convertible bonds and warrant issuance for January 2026. No shares were delivered during the month, and there was no exercise activity related to the bonds. As of the end of January, the remaining unexercised amount stood at ¥125 million. Additionally, the cumulative exercise rate remained unch